Global Parkinson’s Disease Therapeutics Market Report 2021
Global Parkinson’s Disease Therapeutics Market Report 2021
The Global Parkinson s Disease Therapeutics Market investigation report contains Types, Application & all logical and factual briefs about market Overview, CAGR, Production Volume, Sales, Revenue with the regional analysis covers North America, Europe, Asia-Pacific, South America, Middle East & Africa & The top Players like AbbVie, Inc., UCB Inc., Merck & Co., Inc., Valeant Pharmaceuticals International, Inc., Novartis AG, Boehringer Ingelheim GmbH., GlaxoSmithKline plc., Teva Pharmaceutical Industries Ltd., STADA Arzneimittel AG., Impax Laboratories, Inc., F. Hoffmann-La Roche Ltd.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Parkinson’s Disease Therapeutics industries have also been greatly affected.
In the past few years, the Parkinson’s Disease Therapeutics market experienced a growth of 7, the global market size of Parkinson’s Disease Therapeutics reached (2020 Market size XXXX) million $ in 2020, of what is about (2015 Market size XXXX) million $ in 2015.
From 2015 to 2019, the growth rate of global Parkinson’s Disease Therapeutics market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Parkinson’s Disease Therapeutics market size in 2020 will be (2020 Market size XXXX) with a growth rate of xxx%. This is xxx percentage points lower than in previous years.
As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Parkinson’s Disease Therapeutics market size will reach (2025 Market size XXXX) million $ in 2025, with a CAGR of xxx% between 2020-2025.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Free——Definition
Section (2 3): 1200 USD——Manufacturer Detail
AbbVie, Inc.
UCB Inc.
Merck & Co., Inc.
Valeant Pharmaceuticals International, Inc.
Novartis AG
Boehringer Ingelheim GmbH.
GlaxoSmithKline plc.
Teva Pharmaceutical Industries Ltd.
STADA Arzneimittel AG.
Impax Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): 500 USD——
Product Type Segmentation
Levodopa Combination
Dopamine Agonists
MAO-B Inhibitors
COMT Inhibitors
Industry Segmentation
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Channel (Direct Sales, Distributor) Segmentation
Section 8: 400 USD——Trend (2020-2025)
Section 9: 300 USD——Product Type Detail
Section 10: 700 USD——Downstream Consumer
Section 11: 200 USD——Cost Structure
Section 12: 500 USD——Conclusion
Section 1 Parkinson’s Disease Therapeutics Product Definition
Section 2 Global Parkinson’s Disease Therapeutics Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Parkinson’s Disease Therapeutics Shipments
2.2 Global Manufacturer Parkinson’s Disease Therapeutics Business Revenue
2.3 Global Parkinson’s Disease Therapeutics Market Overview
2.4 COVID-19 Impact on Parkinson’s Disease Therapeutics Industry
Section 3 Manufacturer Parkinson’s Disease Therapeutics Business Introduction
3.1 AbbVie, Inc. Parkinson’s Disease Therapeutics Business Introduction
3.1.1 AbbVie, Inc. Parkinson’s Disease Therapeutics Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 AbbVie, Inc. Parkinson’s Disease Therapeutics Business Distribution by Region
3.1.3 AbbVie, Inc. Interview Record
3.1.4 AbbVie, Inc. Parkinson’s Disease Therapeutics Business Profile
3.1.5 AbbVie, Inc. Parkinson’s Disease Therapeutics Product Specification
3.2 UCB Inc. Parkinson’s Disease Therapeutics Business Introduction
3.2.1 UCB Inc. Parkinson’s Disease Therapeutics Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 UCB Inc. Parkinson’s Disease Therapeutics Business Distribution by Region
3.2.3 Interview Record
3.2.4 UCB Inc. Parkinson’s Disease Therapeutics Business Overview
3.2.5 UCB Inc. Parkinson’s Disease Therapeutics Product Specification
3.3 Merck & Co., Inc. Parkinson’s Disease Therapeutics Business Introduction
3.3.1 Merck & Co., Inc. Parkinson’s Disease Therapeutics Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 Merck & Co., Inc. Parkinson’s Disease Therapeutics Business Distribution by Region
3.3.3 Interview Record
3.3.4 Merck & Co., Inc. Parkinson’s Disease Therapeutics Business Overview
3.3.5 Merck & Co., Inc. Parkinson’s Disease Therapeutics Product Specification
3.4 Valeant Pharmaceuticals International, Inc. Parkinson’s Disease Therapeutics Business Introduction
3.5 Novartis AG Parkinson’s Disease Therapeutics Business Introduction
3.6 Boehringer Ingelheim GmbH. Parkinson’s Disease Therapeutics Business Introduction
…
Section 4 Global Parkinson’s Disease Therapeutics Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.1.2 Canada Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.2 South America Country
4.2.1 South America Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.3 Asia Country
4.3.1 China Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.3.2 Japan Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.3.3 India Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.3.4 Korea Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.4 Europe Country
4.4.1 Germany Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.4.2 UK Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.4.3 France Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.4.4 Italy Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.4.5 Europe Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.5 Other Country and Region
4.5.1 Middle East Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.5.2 Africa Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.5.3 GCC Parkinson’s Disease Therapeutics Market Size and Price Analysis 2015-2020
4.6 Global Parkinson’s Disease Therapeutics Market Segmentation (Region Level) Analysis 2015-2020
4.7 Global Parkinson’s Disease Therapeutics Market Segmentation (Region Level) Analysis
Section 5 Global Parkinson’s Disease Therapeutics Market Segmentation (Product Type Level)
5.1 Global Parkinson’s Disease Therapeutics Market Segmentation (Product Type Level) Market Size 2015-2020
5.2 Different Parkinson’s Disease Therapeutics Product Type Price 2015-2020
5.3 Global Parkinson’s Disease Therapeutics Market Segmentation (Product Type Level) Analysis
Section 6 Global Parkinson’s Disease Therapeutics Market Segmentation (Industry Level)
6.1 Global Parkinson’s Disease Therapeutics Market Segmentation (Industry Level) Market Size 2015-2020
6.2 Different Industry Price 2015-2020
6.3 Global Parkinson’s Disease Therapeutics Market Segmentation (Industry Level) Analysis
Section 7 Global Parkinson’s Disease Therapeutics Market Segmentation (Channel Level)
7.1 Global Parkinson’s Disease Therapeutics Market Segmentation (Channel Level) Sales Volume and Share 2015-2020
7.2 Global Parkinson’s Disease Therapeutics Market Segmentation (Channel Level) Analysis
Section 8 Parkinson’s Disease Therapeutics Market Forecast 2020-2025
8.1 Parkinson’s Disease Therapeutics Segmentation Market Forecast (Region Level)
8.2 Parkinson’s Disease Therapeutics Segmentation Market Forecast (Product Type Level)
8.3 Parkinson’s Disease Therapeutics Segmentation Market Forecast (Industry Level)
8.4 Parkinson’s Disease Therapeutics Segmentation Market Forecast (Channel Level)
Section 9 Parkinson’s Disease Therapeutics Segmentation Product Type
9.1 Levodopa Combination Product Introduction
9.2 Dopamine Agonists Product Introduction
9.3 MAO-B Inhibitors Product Introduction
9.4 COMT Inhibitors Product Introduction
Section 10 Parkinson’s Disease Therapeutics Segmentation Industry
10.1 Hospital Pharmacy Clients
10.2 Retail Pharmacy Clients
10.3 Online Pharmacy Clients
Section 11 Parkinson’s Disease Therapeutics Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Parkinson’s Disease Therapeutics Product Picture from AbbVie, Inc.
Chart 2015-2020 Global Manufacturer Parkinson’s Disease Therapeutics Shipments (Units)
Chart 2015-2020 Global Manufacturer Parkinson’s Disease Therapeutics Shipments Share
Chart 2015-2020 Global Manufacturer Parkinson’s Disease Therapeutics Business Revenue (Million USD)
Chart 2015-2020 Global Manufacturer Parkinson’s Disease Therapeutics Business Revenue Share
Chart AbbVie, Inc. Parkinson’s Disease Therapeutics Shipments, Price, Revenue and Gross profit 2015-2020
Chart AbbVie, Inc. Parkinson’s Disease Therapeutics Business Distribution
Chart AbbVie, Inc. Interview Record (Partly)
Figure AbbVie, Inc. Parkinson’s Disease Therapeutics Product Picture
Chart AbbVie, Inc. Parkinson’s Disease Therapeutics Business Profile
Table AbbVie, Inc. Parkinson’s Disease Therapeutics Product Specification
Chart UCB Inc. Parkinson’s Disease Therapeutics Shipments, Price, Revenue and Gross profit 2015-2020
Chart UCB Inc. Parkinson’s Disease Therapeutics Business Distribution
Chart UCB Inc. Interview Record (Partly)
Figure UCB Inc. Parkinson’s Disease Therapeutics Product Picture
Chart UCB Inc. Parkinson’s Disease Therapeutics Business Overview
Table UCB Inc. Parkinson’s Disease Therapeutics Product Specification
Chart Merck & Co., Inc. Parkinson’s Disease Therapeutics Shipments, Price, Revenue and Gross profit 2015-2020
Chart Merck & Co., Inc. Parkinson’s Disease Therapeutics Business Distribution
Chart Merck & Co., Inc. Interview Record (Partly)
Figure Merck & Co., Inc. Parkinson’s Disease Therapeutics Product Picture
Chart Merck & Co., Inc. Parkinson’s Disease Therapeutics Business Overview
Table Merck & Co., Inc. Parkinson’s Disease Therapeutics Product Specification
3.4 Valeant Pharmaceuticals International, Inc. Parkinson’s Disease Therapeutics Business Introduction
…
Chart United States Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart United States Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart Canada Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Canada Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart South America Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart South America Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart China Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart China Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart Japan Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Japan Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart India Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart India Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart Korea Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Korea Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart Germany Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Germany Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart UK Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart UK Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart France Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart France Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart Italy Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Italy Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart Europe Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Europe Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart Middle East Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Middle East Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart Africa Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Africa Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart GCC Parkinson’s Disease Therapeutics Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart GCC Parkinson’s Disease Therapeutics Sales Price ($/Unit) 2015-2020
Chart Global Parkinson’s Disease Therapeutics Market Segmentation (Region Level) Sales Volume 2015-2020
Chart Global Parkinson’s Disease Therapeutics Market Segmentation (Region Level) Market size 2015-2020
Chart Parkinson’s Disease Therapeutics Market Segmentation (Product Type Level) Volume (Units) 2015-2020
Chart Parkinson’s Disease Therapeutics Market Segmentation (Product Type Level) Market Size (Million $) 2015-2020
Chart Different Parkinson’s Disease Therapeutics Product Type Price ($/Unit) 2015-2020
Chart Parkinson’s Disease Therapeutics Market Segmentation (Industry Level) Market Size (Volume) 2015-2020
Chart Parkinson’s Disease Therapeutics Market Segmentation (Industry Level) Market Size (Share) 2015-2020
Chart Parkinson’s Disease Therapeutics Market Segmentation (Industry Level) Market Size (Value) 2015-2020
Chart Global Parkinson’s Disease Therapeutics Market Segmentation (Channel Level) Sales Volume (Units) 2015-2020
Chart Global Parkinson’s Disease Therapeutics Market Segmentation (Channel Level) Share 2015-2020
Chart Parkinson’s Disease Therapeutics Segmentation Market Forecast (Region Level) 2020-2025
Chart Parkinson’s Disease Therapeutics Segmentation Market Forecast (Product Type Level) 2020-2025
Chart Parkinson’s Disease Therapeutics Segmentation Market Forecast (Industry Level) 2020-2025
Chart Parkinson’s Disease Therapeutics Segmentation Market Forecast (Channel Level) 2020-2025
Chart Levodopa Combination Product Figure
Chart Levodopa Combination Product Advantage and Disadvantage Comparison
Chart Dopamine Agonists Product Figure
Chart Dopamine Agonists Product Advantage and Disadvantage Comparison
Chart MAO-B Inhibitors Product Figure
Chart MAO-B Inhibitors Product Advantage and Disadvantage Comparison
Chart COMT Inhibitors Product Figure
Chart COMT Inhibitors Product Advantage and Disadvantage Comparison
Chart Hospital Pharmacy Clients
Chart Retail Pharmacy Clients
Chart Online Pharmacy Clients
Research Methodology:
Parkinson s Disease Therapeutics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|